Table 1.
Age, gender, and diagnosis status of the participants.
| Group | n | Male | Female | Age (years)a | Time since diagnosis (days)a | ALSFRS-R | |
|---|---|---|---|---|---|---|---|
| Control | 19 | 10 | 9 | 61.0 ± 22.5 | – | – | |
| ALS | All | 89 | 63 | 26 | 60.6 ± 11.6 | 275 ± 373 | 36.5 ± 7.7(n = 86) |
| Spinal | 67 | 50 | 17 | 60.0 ± 11.9 | 286 ± 301 | 36.5 ± 7.0(n = 64) | |
| Bulbar | 15 | 9 | 6 | 58.2 ± 9.4 | 216 ± 267 | 35.2 ± 10.7(n = 15) | |
| ALS-FTD | 7 | 4 | 3 | 71.5 ± 6.9 | 289 ± 301 | 38.9 ± 7.1(n = 7) | |
| C9ORF72+ | 7 | 3 | 4 | 58.1 ± 9.4 | 336 ± 167 | 39.7 ± 8.6(n = 9) | |
| C9ORF72− | 63 | 48 | 15 | 61.9 ± 11.5 | 288 ± 412 | 36.2 ± 7.6(n = 64) |
aMean ± SD.
ALS, amyotrophic lateral sclerosis; ALSFRS-R, Revised ALS Functional Rating Scale.